Report Thumbnail
Product Code LP0913214527QU
Published Date 2026/5/18
English118 PagesGlobal

Global NC Membrane (For LFA) Market Growth 2026-2032 ‐ MedicalDevice / MedTech Market


Report Thumbnail
Product Code LP0913214527QU◆An updated version may be available. We will check for you.
Published Date 2026/5/18
English 118 PagesGlobal

Global NC Membrane (For LFA) Market Growth 2026-2032 ‐ MedicalDevice / MedTech Market



Abstract

This report provides a comprehensive analysis of the global NC Membrane (For LFA) market, projecting steady growth through 2032. It examines critical product segments, including membrane thickness and wicking rates, while highlighting medical diagnostics and point-of-care testing as the dominant applications. Driven by the expansion of home testing and diversified diagnostic portfolios, the market is shifting toward high-throughput, automated, and standardized solutions. The study further evaluates regional dynamics, particularly in the Asia-Pacific region, and profiles key industry players and competitive strategies.

Related Questions

US$ 101 million in 2025; US$ 171 million in 2032

8.6% (2026-2032)

Merck, Sartorius, Danaher (Cytiva), AMD (MDI), Suzhou Tianren, Advantec, Equinox Biotech, Zhejiang Tailin Bioengineering, BSK Basic, Beijia New Material, Kingfa, Cobetter

High-throughput roll-to-roll supply and automation-friendly specifications, Improving sensitivity and specificity through capillary action and pore structure control, Multiplexing and high-throughput automated membranes


Summary

Market Overview

Market Size and Growth Projections

The global NC Membrane (For LFA) market is projected to grow from US$ 101 million in 2025 to US$ 171 million in 2032, representing a compound annual growth rate (CAGR) of 8.6% from 2026 to 2032.

Product Definition and Functionality

In the context of this report, NC membrane primarily refers to analytical/reaction membranes, which are typically nitrocellulose (NC) membranes laminated onto a backing. These porous, capillary-driven substrate materials are utilized in lateral flow test strips to facilitate liquid transport and immunoreaction on the strip.

Key technical characteristics include:

  • Capillary Action: Strong capillary action enables the lateral migration of liquid samples.
  • Protein Binding: High protein binding capacity allows for the capture and immobilization of biological reagents on both the test and control lines.
  • Detection Mechanism: As the liquid sample migrates, labeled detection conjugates (such as gold, latex, or fluorescent particles) form complexes with the target analyte. These complexes are captured on the test line to generate a visible or quantifiable signal, while the control line confirms the proper functioning of the flow and reagents.

Industry Value Chain

Upstream

  • Raw Materials: Cellulose (including nitrocellulose and cellulose acetate), wetting agent liquid, solvents (methyl acetate, ethanol, dibutanol), PET film, and glassine paper.
  • Equipment: Coating and cutting equipment, quality testing equipment, and other related machinery.

Downstream

  • End Users: In vitro diagnostics (IVD) and point-of-care testing (POCT) companies.

Market Dynamics and Trends

Historical Context and Recent Volatility

  • Pandemic Impact: Between 2021 and 2025, the market experienced a period of contraction due to the surge in demand caused by the COVID-19 pandemic between 2020 and 2022. This surge, coupled with supply chain instability, led to a significant increase in product prices.
  • Post-Pandemic Correction: In 2023 and 2024, as the pandemic's impact subsided, both product sales volume and prices declined, resulting in total market revenue in 2024 being lower than in 2021.

Emerging Market Trends

  • Multi-scenario, Long-cycle Consumption: Following the peak of the COVID-19 pandemic, LFA has maintained stable consumer demand in areas such as infectious diseases, women's health, substance abuse, food safety, and veterinary testing. Future demand is expected to be driven by diversified testing product portfolios rather than single blockbuster products, placing greater emphasis on supply continuity and batch-to-batch consistency.
  • Home Testing and Retail Expansion: Home testing (particularly for women's health and respiratory infections) remains a primary demand driver. The shift toward home testing is driving the development of NC membranes toward high-throughput roll-to-roll supply, automation-friendly specifications, and stricter control over capillary rate variations and background values.
  • Price Competition in Mature Segments: In the post-pandemic market, human chorionic gonadotropin (HCG) testing is the largest application area. As this field is mature, companies are competing through price and cost reductions, frequently utilizing 20mm or 18mm pure nitrocellulose (NC) products.
  • High Sensitivity and Lower Detection Limits: Recent LFA developments focus on improving sensitivity and specificity through signal enhancement, sample enrichment, advanced labeling, and improved analytical methods. This requires membranes to balance speed and performance through optimized pore structure, surfactant treatments, and capillary action times.
  • Multiplex Detection: The advancement of detecting multiple targets on a single strip/cassette requires membranes with uniform surface chemistry/porosity, consistent multi-strip performance, lower background, and stable lateral flow characteristics.
  • Automation and Standardization: There is growing demand for high-throughput, automated, and standardized membranes driven by multiplexing, digital readings, and POCT applications in public health, food safety, and environmental monitoring.

Market Segmentation

By Type (Thickness)

  • Membranes $\le$ 250 $\mu$m: Heavily utilized in 2024 and 2025; projected to account for 89.3% of the global sales market share in 2025.
  • Membranes > 250 $\mu$m

By Material

  • Polyester-backed NC
  • Unbacked Nitrocellulose (NC)

By Wicking Rate (s/4 cm)

  • Standard-Flow (Medium): 100–140s/4cm
  • High-Flow (Fast): <100s/4cm
  • Low-Flow (Slow): >140s/4cm

By Application

  • Medical Diagnostics and Point-of-Care (POC): The most widely used area, projected to account for approximately 79.82% of the global market size by 2025.
  • Drug of Abuse Testing
  • Food Safety and Environmental
  • Other Applications

Regional Analysis

Global Supply Landscape

  • Main Suppliers: The United States, the European Union, China, and India.

Regional Market Share

  • Asia-Pacific: The largest market region for several years and expected to continue growing. By 2024, it is projected to account for approximately 41.54% of the global market share.
  • Europe: Projected to account for approximately 27.63% of the market share.
  • North America: Projected to account for approximately 23.83% of the market share.

Regional Breakdown for Report Coverage

  • Americas: United States, Canada, Mexico, Brazil
  • APAC: China, Japan, Korea, Southeast Asia, India, Australia
  • Europe: Germany, France, UK, Italy, Russia
  • Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Market Metrics

  • Gross Margin: In 2025, global NC Membrane (For LFA) company gross margins ranged from approximately 44.36% to 59.54%.
  • Pricing and Units:
  • Units of Measure: Some companies use "rolls" (100 meters/roll), while others use "sheets" or "square meters" (1 square meter/sheet).
  • Retail Pricing: Ranges from approximately $100 to $285 per roll. Leading international companies generally command higher prices than Chinese manufacturers.
  • Production Capacity: Varies significantly by company; small businesses may operate a single production line producing 3,000 rolls per month, while larger players produce approximately 300,000 square meters annually.
  • Usage Projection: Based on "test counts," global NC membrane production is projected to reach 9,556 million tests by 2025.

Major Manufacturers

  • Market Concentration: The top five manufacturers are projected to account for approximately 80.15% of the global market share by 2025.
  • Key Players Profiled:
  • Merck
  • Sartorius
  • Danaher (Cytiva)
  • Advantec
  • Advanced Microdevices (MDI)
  • Equinox Biotech
  • Tianren
  • Zhejiang Tailin Bioengineering
  • BSK Basic
  • Beijia New Material
  • Kingfa
  • Cobetter

Report Scope and Methodology

This research report by LP Information, Inc. (LPI) provides a comprehensive analysis of the global NC Membrane (For LFA) industry. It covers past sales and reviews total world sales in 2025, providing detailed analysis in US$ millions for the forecast period of 2026 through 2032.

The report highlights:

  • Trends related to product segmentation, company formation, revenue, market share, latest developments, and M&A activity.
  • Strategies of leading global companies, including portfolios, capabilities, market entry strategies, market positions, and geographic footprints.
  • A transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs.

Key Questions Addressed

  • What is the 10-year outlook for the global NC Membrane (For LFA) market?
  • What factors are driving NC Membrane (For LFA) market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do NC Membrane (For LFA) market opportunities vary by end market size?
  • How does NC Membrane (For LFA) break out by Type and by Application?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global NC Membrane (For LFA) Annual Sales 2021-2032
      • 2.1.2 World Current & Future Analysis for NC Membrane (For LFA) by Geographic Region, 2021, 2025 & 2032
      • 2.1.3 World Current & Future Analysis for NC Membrane (For LFA) by Country/Region, 2021, 2025 & 2032
    • 2.2 NC Membrane (For LFA) Segment by Type
      • 2.2.1 Thickness max. 250 µm
      • 2.2.2 Thickness above 250 µm
      • 2.2.3 NC Membrane (For LFA) Sales by Type
        • 2.2.3.1 Global NC Membrane (For LFA) Sales Market Share by Type (2021-2026)
        • 2.2.3.2 Global NC Membrane (For LFA) Revenue and Market Share by Type (2021-2026)
        • 2.2.3.3 Global NC Membrane (For LFA) Sale Price by Type (2021-2026)
    • 2.3 NC Membrane (For LFA) Segment by Material
      • 2.3.1 Polyester‑backed NC
      • 2.3.2 Unbacked Nitrocellulose (NC)
      • 2.3.3 NC Membrane (For LFA) Sales by Material
        • 2.3.3.1 Global NC Membrane (For LFA) Sales Market Share by Material (2021-2026)
        • 2.3.3.2 Global NC Membrane (For LFA) Revenue and Market Share by Material (2021-2026)
        • 2.3.3.3 Global NC Membrane (For LFA) Sale Price by Material (2021-2026)
    • 2.4 NC Membrane (For LFA) Segment by Wicking Rate (s/4 cm)
      • 2.4.1 Standard-Flow (Medium): 100–140s/4cm
      • 2.4.2 High-Flow (Fast): &lt;100s/4cm
      • 2.4.3 Low-Flow (Slow): &gt;140s/4cm
      • 2.4.4 NC Membrane (For LFA) Sales by Wicking Rate (s/4 cm)
        • 2.4.4.1 Global NC Membrane (For LFA) Sales Market Share by Wicking Rate (s/4 cm) (2021-2026)
        • 2.4.4.2 Global NC Membrane (For LFA) Revenue and Market Share by Wicking Rate (s/4 cm) (2021-2026)
        • 2.4.4.3 Global NC Membrane (For LFA) Sale Price by Wicking Rate (s/4 cm) (2021-2026)
    • 2.5 NC Membrane (For LFA) Segment by Application
      • 2.5.1 Medical Diagnostics and Point-of-Care (POC)
      • 2.5.2 Drug of Abuse Testing
      • 2.5.3 Food Safety and Environmental
      • 2.5.4 Other Applications
      • 2.5.5 NC Membrane (For LFA) Sales by Application
        • 2.5.5.1 Global NC Membrane (For LFA) Sale Market Share by Application (2021-2026)
        • 2.5.5.2 Global NC Membrane (For LFA) Revenue and Market Share by Application (2021-2026)
        • 2.5.5.3 Global NC Membrane (For LFA) Sale Price by Application (2021-2026)
  • 3 Global by Company

    • 3.1 Global NC Membrane (For LFA) Breakdown Data by Company
      • 3.1.1 Global NC Membrane (For LFA) Annual Sales by Company (2021-2026)
      • 3.1.2 Global NC Membrane (For LFA) Sales Market Share by Company (2021-2026)
    • 3.2 Global NC Membrane (For LFA) Annual Revenue by Company (2021-2026)
      • 3.2.1 Global NC Membrane (For LFA) Revenue by Company (2021-2026)
      • 3.2.2 Global NC Membrane (For LFA) Revenue Market Share by Company (2021-2026)
    • 3.3 Global NC Membrane (For LFA) Sale Price by Company
    • 3.4 Key Manufacturers NC Membrane (For LFA) Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers NC Membrane (For LFA) Product Location Distribution
      • 3.4.2 Players NC Membrane (For LFA) Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    • 3.6 New Products and Potential Entrants
    • 3.7 Market M&A Activity & Strategy
  • 4 World Historic Review for NC Membrane (For LFA) by Geographic Region

    • 4.1 World Historic NC Membrane (For LFA) Market Size by Geographic Region (2021-2026)
      • 4.1.1 Global NC Membrane (For LFA) Annual Sales by Geographic Region (2021-2026)
      • 4.1.2 Global NC Membrane (For LFA) Annual Revenue by Geographic Region (2021-2026)
    • 4.2 World Historic NC Membrane (For LFA) Market Size by Country/Region (2021-2026)
      • 4.2.1 Global NC Membrane (For LFA) Annual Sales by Country/Region (2021-2026)
      • 4.2.2 Global NC Membrane (For LFA) Annual Revenue by Country/Region (2021-2026)
    • 4.3 Americas NC Membrane (For LFA) Sales Growth
    • 4.4 APAC NC Membrane (For LFA) Sales Growth
    • 4.5 Europe NC Membrane (For LFA) Sales Growth
    • 4.6 Middle East & Africa NC Membrane (For LFA) Sales Growth
  • 5 Americas

    • 5.1 Americas NC Membrane (For LFA) Sales by Country
      • 5.1.1 Americas NC Membrane (For LFA) Sales by Country (2021-2026)
      • 5.1.2 Americas NC Membrane (For LFA) Revenue by Country (2021-2026)
    • 5.2 Americas NC Membrane (For LFA) Sales by Type (2021-2026)
    • 5.3 Americas NC Membrane (For LFA) Sales by Application (2021-2026)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC NC Membrane (For LFA) Sales by Region
      • 6.1.1 APAC NC Membrane (For LFA) Sales by Region (2021-2026)
      • 6.1.2 APAC NC Membrane (For LFA) Revenue by Region (2021-2026)
    • 6.2 APAC NC Membrane (For LFA) Sales by Type (2021-2026)
    • 6.3 APAC NC Membrane (For LFA) Sales by Application (2021-2026)
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe NC Membrane (For LFA) by Country
      • 7.1.1 Europe NC Membrane (For LFA) Sales by Country (2021-2026)
      • 7.1.2 Europe NC Membrane (For LFA) Revenue by Country (2021-2026)
    • 7.2 Europe NC Membrane (For LFA) Sales by Type (2021-2026)
    • 7.3 Europe NC Membrane (For LFA) Sales by Application (2021-2026)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa NC Membrane (For LFA) by Country
      • 8.1.1 Middle East & Africa NC Membrane (For LFA) Sales by Country (2021-2026)
      • 8.1.2 Middle East & Africa NC Membrane (For LFA) Revenue by Country (2021-2026)
    • 8.2 Middle East & Africa NC Membrane (For LFA) Sales by Type (2021-2026)
    • 8.3 Middle East & Africa NC Membrane (For LFA) Sales by Application (2021-2026)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of NC Membrane (For LFA)
    • 10.3 Manufacturing Process Analysis of NC Membrane (For LFA)
    • 10.4 Industry Chain Structure of NC Membrane (For LFA)
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 NC Membrane (For LFA) Distributors
    • 11.3 NC Membrane (For LFA) Customer
  • 12 World Forecast Review for NC Membrane (For LFA) by Geographic Region

    • 12.1 Global NC Membrane (For LFA) Market Size Forecast by Region
      • 12.1.1 Global NC Membrane (For LFA) Forecast by Region (2027-2032)
      • 12.1.2 Global NC Membrane (For LFA) Annual Revenue Forecast by Region (2027-2032)
    • 12.2 Americas Forecast by Country (2027-2032)
    • 12.3 APAC Forecast by Region (2027-2032)
    • 12.4 Europe Forecast by Country (2027-2032)
    • 12.5 Middle East & Africa Forecast by Country (2027-2032)
    • 12.6 Global NC Membrane (For LFA) Forecast by Type (2027-2032)
    • 12.7 Global NC Membrane (For LFA) Forecast by Application (2027-2032)
  • 13 Key Players Analysis

    • 13.1 Merck
      • 13.1.1 Merck Company Information
      • 13.1.2 Merck NC Membrane (For LFA) Product Portfolios and Specifications
      • 13.1.3 Merck NC Membrane (For LFA) Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.1.4 Merck Main Business Overview
      • 13.1.5 Merck Latest Developments
    • 13.2 Sartorius
      • 13.2.1 Sartorius Company Information
      • 13.2.2 Sartorius NC Membrane (For LFA) Product Portfolios and Specifications
      • 13.2.3 Sartorius NC Membrane (For LFA) Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.2.4 Sartorius Main Business Overview
      • 13.2.5 Sartorius Latest Developments
    • 13.3 Danaher (Cytiva)
      • 13.3.1 Danaher (Cytiva) Company Information
      • 13.3.2 Danaher (Cytiva) NC Membrane (For LFA) Product Portfolios and Specifications
      • 13.3.3 Danaher (Cytiva) NC Membrane (For LFA) Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.3.4 Danaher (Cytiva) Main Business Overview
      • 13.3.5 Danaher (Cytiva) Latest Developments
    • 13.4 Advantec
      • 13.4.1 Advantec Company Information
      • 13.4.2 Advantec NC Membrane (For LFA) Product Portfolios and Specifications
      • 13.4.3 Advantec NC Membrane (For LFA) Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.4.4 Advantec Main Business Overview
      • 13.4.5 Advantec Latest Developments
    • 13.5 Advanced Microdevices (MDI)
      • 13.5.1 Advanced Microdevices (MDI) Company Information
      • 13.5.2 Advanced Microdevices (MDI) NC Membrane (For LFA) Product Portfolios and Specifications
      • 13.5.3 Advanced Microdevices (MDI) NC Membrane (For LFA) Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.5.4 Advanced Microdevices (MDI) Main Business Overview
      • 13.5.5 Advanced Microdevices (MDI) Latest Developments
    • 13.6 Equinox Biotech
      • 13.6.1 Equinox Biotech Company Information
      • 13.6.2 Equinox Biotech NC Membrane (For LFA) Product Portfolios and Specifications
      • 13.6.3 Equinox Biotech NC Membrane (For LFA) Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.6.4 Equinox Biotech Main Business Overview
      • 13.6.5 Equinox Biotech Latest Developments
    • 13.7 Tianren
      • 13.7.1 Tianren Company Information
      • 13.7.2 Tianren NC Membrane (For LFA) Product Portfolios and Specifications
      • 13.7.3 Tianren NC Membrane (For LFA) Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.7.4 Tianren Main Business Overview
      • 13.7.5 Tianren Latest Developments
    • 13.8 Zhejiang Tailin Bioengineering
      • 13.8.1 Zhejiang Tailin Bioengineering Company Information
      • 13.8.2 Zhejiang Tailin Bioengineering NC Membrane (For LFA) Product Portfolios and Specifications
      • 13.8.3 Zhejiang Tailin Bioengineering NC Membrane (For LFA) Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.8.4 Zhejiang Tailin Bioengineering Main Business Overview
      • 13.8.5 Zhejiang Tailin Bioengineering Latest Developments
    • 13.9 BSK Basic
      • 13.9.1 BSK Basic Company Information
      • 13.9.2 BSK Basic NC Membrane (For LFA) Product Portfolios and Specifications
      • 13.9.3 BSK Basic NC Membrane (For LFA) Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.9.4 BSK Basic Main Business Overview
      • 13.9.5 BSK Basic Latest Developments
    • 13.10 Beijia New Material
      • 13.10.1 Beijia New Material Company Information
      • 13.10.2 Beijia New Material NC Membrane (For LFA) Product Portfolios and Specifications
      • 13.10.3 Beijia New Material NC Membrane (For LFA) Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.10.4 Beijia New Material Main Business Overview
      • 13.10.5 Beijia New Material Latest Developments
    • 13.11 Kingfa
      • 13.11.1 Kingfa Company Information
      • 13.11.2 Kingfa NC Membrane (For LFA) Product Portfolios and Specifications
      • 13.11.3 Kingfa NC Membrane (For LFA) Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.11.4 Kingfa Main Business Overview
      • 13.11.5 Kingfa Latest Developments
    • 13.12 Cobetter
      • 13.12.1 Cobetter Company Information
      • 13.12.2 Cobetter NC Membrane (For LFA) Product Portfolios and Specifications
      • 13.12.3 Cobetter NC Membrane (For LFA) Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.12.4 Cobetter Main Business Overview
      • 13.12.5 Cobetter Latest Developments
  • 14 Research Findings and Conclusion

USD 7,320 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.